Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Am J Respir Crit Care Med ; 208(12): 1344-1345, 2023 Dec 15.
Article in English | MEDLINE | ID: mdl-37856837
3.
BMC Pulm Med ; 23(1): 114, 2023 Apr 11.
Article in English | MEDLINE | ID: mdl-37041499

ABSTRACT

BACKGROUND: Idiopathic pulmonary fibrosis is thought to result from aberrant post-injury activation of epithelial cells leading to fibroblast proliferation and activation. A number of genetic aetiologies have been implicated in this disease process, including, among others, the short telomere syndromes. Short telomere syndromes follow an autosomal dominant pattern of inheritance resulting in shortened telomere length, which consequently leads to accelerated cell death. Organs with rapid cell turnover are most affected. CASE PRESENTATION: We describe a case of a 53-year-old man with a chief complaint of cough and dyspnea on exertion. His presentation was otherwise significant for features of accelerated aging, including a history of osteoporosis and early greying, and a family history of pulmonary fibrosis in his father. Pulmonary function testing revealed a restrictive pattern with severely reduced diffusion capacity and high resolution CT of the chest showed diffuse lung disease with mild fibrosis, in pattern suggesting an alternative diagnosis to IPF. Biopsy of the lung was in keeping with chronic fibrosing interstitial pneumonia. Imaging of the abdomen showed splenomegaly, hepatic cirrhosis and portal hypertension. Transthoracic contrast echocardiogram showed intrapulmonary shunting consistent with hepatopulmonary syndrome. Given the constellation of early aging, idiopathic pulmonary fibrosis, cryptogenic cirrhosis and a family history of pulmonary fibrosis in this patient, the Short Telomere Syndrome was suspected. Peripheral blood was sent for Flow-cytometry FISH, which demonstrated granulocyte telomere length below the 10th percentile for the patient's age, consistent with a diagnosis of Short Telomere Syndrome in this clinical context. Targeted genetic testing of mutations known to be associated with short telomere was negative though it was acknowledged that the full spectrum of disease-causing mutations remains unknown. Given the extensive fibrosis on biopsy and his progressive hypoxemia he was treated with mycophenolate and prednisone. Ultimately, he developed progressive respiratory failure and underwent double lung and concurrent liver transplant 18 months after the initial diagnosis was made. CONCLUSIONS: Short Telomere Syndrome is a rare cause of end stage organ disease and testing lacks sensitivity making diagnosis challenging. Organ transplant is still the mainstay of treatment. Nevertheless, disease identification is important because of implications for family member screening and the possibility of future treatment options.


Subject(s)
Hepatopulmonary Syndrome , Idiopathic Pulmonary Fibrosis , Lung Diseases, Interstitial , Male , Humans , Hepatopulmonary Syndrome/complications , Hepatopulmonary Syndrome/therapy , Telomere Shortening , Telomere , Liver Cirrhosis/complications , Fibrosis , Idiopathic Pulmonary Fibrosis/complications , Lung Diseases, Interstitial/complications
4.
Eur Respir J ; 61(2)2023 Feb.
Article in English | MEDLINE | ID: mdl-36328359

ABSTRACT

BACKGROUND: It remains unclear why some symptomatic individuals with asthma or COPD remain undiagnosed. Here, we compare patient and physician characteristics between symptomatic individuals with obstructive lung disease (OLD) who are undiagnosed and individuals with physician-diagnosed OLD. METHODS: Using random-digit dialling and population-based case finding, we recruited 451 participants with symptomatic undiagnosed OLD and 205 symptomatic control participants with physician-diagnosed OLD. Data on symptoms, quality of life and healthcare utilisation were analysed. We surveyed family physicians of participants in both groups to elucidate differences in physician practices that could contribute to undiagnosed OLD. RESULTS: Participants with undiagnosed OLD had lower mean pre-bronchodilator forced expiratory volume in 1 s percentage predicted compared with those who were diagnosed (75.2% versus 80.8%; OR 0.975, 95% CI 0.963-0.987). They reported greater psychosocial impacts due to symptoms and worse energy and fatigue than those with diagnosed OLD. Undiagnosed OLD was more common in participants whose family physicians were practising for >15 years and in those whose physicians reported that they were likely to prescribe respiratory medications without doing spirometry. Undiagnosed OLD was more common among participants who had never undergone spirometry (OR 10.83, 95% CI 6.18-18.98) or who were never referred to a specialist (OR 5.92, 95% CI 3.58-9.77). Undiagnosed OLD was less common among participants who had required emergency department care (OR 0.44, 95% CI 0.20-0.97). CONCLUSIONS: Individuals with symptomatic undiagnosed OLD have worse pre-bronchodilator lung function and present with greater psychosocial impacts on quality of life compared with their diagnosed counterparts. They were less likely to have received appropriate investigations and specialist referral for their respiratory symptoms.


Subject(s)
Asthma , Physicians , Pulmonary Disease, Chronic Obstructive , Humans , Quality of Life , Bronchodilator Agents/therapeutic use , Asthma/drug therapy , Forced Expiratory Volume , Spirometry
5.
JAMA Netw Open ; 5(7): e2220671, 2022 07 01.
Article in English | MEDLINE | ID: mdl-35788669

ABSTRACT

Importance: The most suitable analytic method to systematically analyze numerous trials with contradictory results is unclear. Multiple trials assessing the use of N-acetylcysteine (NAC) for prevention of contrast-induced acute kidney injury (CI-AKI) have had contradictory results with recent trials confirming a lack of benefit. Objective: To systematically review the literature on NAC for the prevention of CI-AKI, and to explore the heterogeneity, publication bias, and small-study effect to determine the most suitable analytic method in a setting where the literature is contradictory. Data Sources: Medline, Embase, and Cochrane Central Register of Controlled Trials databases were used to find randomized clinical trials (RCTs) comparing NAC with any other prophylactic agent or placebo in adults. Study Selection: The search included studies published in English from database inception to January 2020. Two independent reviewers screened the studies, extracted data, and performed the risk of bias assessment. Data Extraction and Synthesis: A meta-analysis was conducted about the effect of NAC on CI-AKI, the need for dialysis, and mortality. Fixed and random effects analyses were also performed. Funnel plots and the trim and fill method were used for assessment of publication bias. Metaregression was performed to explore the heterogeneity and subgroup analysis to examine the association between NAC and CI-AKI when studies were categorized according to sample size and number of events. Results: A total of 101 trials were included in this meta-analysis. The median sample size was 112 (range, 20 to 4993). Twenty-nine trials had a sample size of 200 or more, and only 3 trials had a sample size of 500 or more. Forty-five trials reported the need for kidney replacement therapy, and 41 trials reported mortality as an outcome. NAC seemed to show a benefit, with a pooled OR of 0.72 (95% CI, 0.63-0.82) using random effects model and a pooled OR of 0.82 (95% CI 0.76-0.90) using a fixed effects model. However, there was significant heterogeneity (I2 = 37.6; P < .001) and significant publication bias, which was reduced only when restricting to large RCTs (N ≥ 500). The clinical outcomes (ie, the need for kidney replacement therapy and mortality) revealed little heterogeneity and no publication bias, and each provided a robust neutral summary result. Conclusions and Relevance: In this meta-analysis, NAC was associated with a benefit in the prevention of CI-AKI. However, because of substantial publication bias and other biases, standard meta-analytic techniques resulted in significant heterogeneity and a spurious, or factitious, association, even when using a random effects model. When the analysis was restricted to RCTs with a large sample size to account for publication bias or restricted to trials with clinical outcomes, this issue was reduced and resulted in more robust and neutral effect sizes.


Subject(s)
Acetylcysteine , Acute Kidney Injury , Acetylcysteine/adverse effects , Acetylcysteine/therapeutic use , Acute Kidney Injury/chemically induced , Acute Kidney Injury/prevention & control , Humans , Publication Bias , Renal Dialysis , Renal Replacement Therapy
7.
JCO Oncol Pract ; 17(8): 465-471, 2021 08.
Article in English | MEDLINE | ID: mdl-33720756

ABSTRACT

Treatment for metastatic non-small-cell lung carcinoma has seen important advances in recent years with the introduction of targeted therapies and immunotherapy. Immune checkpoint inhibitors, which target the programmed death 1 receptor and programmed death ligand-1, alone or in combination with platinum-based chemotherapy, have become standard of care in the first-line setting for patients with advanced non-small-cell lung carcinoma without targetable driver mutations. However, several clinical questions have now since emerged. Physicians treating lung cancer lack guidance when treating patients who have a poor performance status, patients who are receiving corticosteroids, and those known for pre-existing autoimmune disorders. Furthermore, data are scarce on rechallenging a patient with immune checkpoint inhibitors after the occurrence of a significant immune-related adverse event. In this review, we aim to shed light on these topics.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Carcinoma, Non-Small-Cell Lung/drug therapy , Humans , Immune Checkpoint Inhibitors , Immunologic Factors/therapeutic use , Immunotherapy , Lung Neoplasms/therapy
8.
BMC Med Educ ; 19(1): 471, 2019 Dec 26.
Article in English | MEDLINE | ID: mdl-31878974

ABSTRACT

BACKGROUND: Several studies have warned about the diminishing physician-scientist breed. Limited studies, however, have attempted to assess what factors (if any) enhanced or hindered the experience of trainee physician-scientists and their supervisors. Using Vroom's expectancy theory as a conceptual framework, we explored the highlights, motivations and barriers of an intercalated MBChB/PhD programme as experienced by students of the programme and their supervisors. METHODS: Previous and current students of the MBChB/PhD programme at the University of Otago, and their supervisors, were invited to provide comments on the programme. Data were analysed using a general inductive approach which involved coding responses, and grouping codes into common themes via an iterative process. A deductive approach was used to interpret the themes and relate them to Vroom's expectancy theory. RESULTS: A total of 22 students (88% response rate) and 36 supervisors (58.3% response rate) responded to our survey. Three themes were identified through the analysis of the students' responses. These were: motives for undertaking the intercalated degree, effect on career development, and perceived barriers. Supervisors' survey yielded two themes: characteristics of successful students, and optimising the intercalated programme. CONCLUSIONS: The current study sheds light on the successes and challenges of an intercalated MBChB/PhD programme by considering the views of those most involved. Whereas the combined programme has its advantages for student research and career development, extending the research-time may be worthwhile. Further studies involving a larger cohort of intercalating students and their supervisors may allow for extrapolation of data to address these concerns.


Subject(s)
Career Choice , Curriculum , Faculty, Medical/psychology , Science , Students, Medical/psychology , Health Knowledge, Attitudes, Practice , Humans , Models, Theoretical , New Zealand , Qualitative Research , Surveys and Questionnaires
10.
Adv Med Educ Pract ; 10: 263-271, 2019.
Article in English | MEDLINE | ID: mdl-31118864

ABSTRACT

Background: Research is increasingly being emphasized from an early stage in medical students' careers. Medical student involvement in research and authorship of peer-reviewed manuscripts have been shown to enhance their academic performance-both in the short term and long term. The aim of this study was to evaluate outcomes and motivations of the summer studentship research program at our institution, using Vroom's expectancy theory as a conceptual framework. Methods: We utilized a mixed-methods approach to our study. Two databases (PubMed™ and Google Scholar™) were searched for publication data. In addition, students and supervisors of the program at the University of Otago were invited to provide comments on the program. Qualitative data were analyzed using an inductive, pragmatic approach which involved coding responses and grouping codes into common themes. Results: Between 2007 and 2016, 1,345 projects were completed, of which 326 (24.2%) resulted in a peer-reviewed publication. Students made up 48.1% of the first-authors. Three themes each emerged from the students and the supervisors' survey. Student themes included: motives for undertaking a summer studentship, administrative benefits and barriers, and perceived outcomes of the program. Supervisor themes included: motivations for engaging in the summer studentship program, administrative benefits and barriers, and expectations placed on the student. These themes are consistent with Vroom's expectancy theory where motivation is related to expectancy, instrumentality, and valence. Conclusion: A dedicated program to foster an interest in research by medical students has great value as judged by an overall publication rate of 24.2%. In addition, it provides opportunities to explore areas of interest in depth, acquire research skills, pilot new avenues of research, and create professional networks. Student research program needs to be well founded and well supported including administrative and statistical support.

SELECTION OF CITATIONS
SEARCH DETAIL
...